Cargando…

Radiotherapy for stage IIA rectal cancer may not benefit all

This study sought to determine whether additional radiotherapy is necessary in patients after optimal surgery for stage IIA rectal cancer and how the different covariates influence the efficacy of radiotherapy. The first primary rectal cancer was identified from the 1988–December 2013 Surveillance,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiang, Li, Ya-Qi, Li, Qing-Guo, Ma, Yan-Lei, Peng, Jun-Jie, Cai, San-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725105/ https://www.ncbi.nlm.nih.gov/pubmed/29245914 http://dx.doi.org/10.18632/oncotarget.19683

Ejemplares similares

Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study
por: Mo, Shaobo, et al.
Publicado: (2018)

Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
por: Hu, Xiang, et al.
Publicado: (2019)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer
por: Gan, Yi-xiu, et al.
Publicado: (2021)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
por: Wu, Lei-Lei, et al.
Publicado: (2021)

Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching
por: Yan, Han, et al.
Publicado: (2022)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers
por: Hu, Xiang, et al.
Publicado: (2018)

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer
por: Zhou, Juan, et al.
Publicado: (2016)

Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
por: Zhou, Jin, et al.
Publicado: (2023)

In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014)

Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases
por: Zhang, Yuan, et al.
Publicado: (2016)

Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit
por: de Jong, R., et al.
Publicado: (2020)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer
por: Beskow, C, et al.
Publicado: (2006)

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry
por: Jones, David A., et al.
Publicado: (2022)

Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor
por: Li, Yi-Wei, et al.
Publicado: (2021)

Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
por: Li, Lei, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic System
por: Xu, Qing-Qing, et al.
Publicado: (2016)

Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
por: Kunneman, M, et al.
Publicado: (2015)

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update
por: Landoni, Fabio, et al.
Publicado: (2017)

Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer
por: Fitzgerald, Timothy L., et al.
Publicado: (2013)

Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer
por: Sarasqueta, Cristina, et al.
Publicado: (2020)

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer
por: Wang, Lei, et al.
Publicado: (2021)

Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy
por: Jan, I-Shiow, et al.
Publicado: (2023)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18
por: Wang, Xiaoshen, et al.
Publicado: (2021)

Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences
por: Pieterse, A H, et al.
Publicado: (2007)

The benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study
por: Bird, David, et al.
Publicado: (2021)

Mesorectal radiotherapy for early stage rectal cancer: A novel target volume
por: Peters, Femke P., et al.
Publicado: (2020)

Octogenarians may benefit from stage-specific small cell lung cancer treatment
por: Zhou, Bin, et al.
Publicado: (2021)

Tanshinone IIA induces apoptosis via inhibition of Wnt/β-catenin/MGMT signaling in AtT-20 cells
por: Li, Zong-Yang, et al.
Publicado: (2017)

LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients
por: Li, Yan, et al.
Publicado: (2020)

Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
por: Peng, Junjie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2gv0s2e9m0nsqp98p8o6k8rkj1